Charlotte C. van Ruiten

Mechanisms underlying the blood pressure lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized trial

Charlotte C. van Ruiten, Mark M. Smits, Megan D. Kok et al. · Cardiovascular Diabetology · 2022 · 54 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial

Charlotte C. van Ruiten, Annemarie B. van der Aart‐van der Beek, Richard G. IJzerman et al. · Diabetes Obesity and Metabolism · 2021 · 52 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effects of Dapagliflozin and Combination Therapy With Exenatide on Food-Cue Induced Brain Activation in Patients With Type 2 Diabetes

Charlotte C. van Ruiten, Dick J. Veltman, Anouk Schrantee et al. · The Journal of Clinical Endocrinology & Metabolism · 2022 · 33 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Eating behavior modulates the sensitivity to the central effects of GLP-1 receptor agonist treatment: a secondary analysis of a randomized trial

Charlotte C. van Ruiten, Jennifer S. ten Kulve, Liselotte van Bloemendaal et al. · Psychoneuroendocrinology · 2022 · 29 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Combination therapy with exenatide decreases the dapagliflozin‐induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial

Charlotte C. van Ruiten, Dick J. Veltman, Madelief Wijdeveld et al. · Diabetes Obesity and Metabolism · 2022 · 25 citations · Full text

Medicine, Neuroscience, Pharmacology +17